Comments to FDA: Antiplaque, Antigingivitis Share page: Docket Number: 81N-033P Comments regarding "Oral Health Care Drug Products for Over-the-Counter Human Use; Antigingivitis/Antiplaque Drug Products; Establishment of a Monograph". Download Document Issues: OTC Medicines Related Posts Press Releases and Statements CHPA Response to Study Examining Prescription Acid Reflux Drugs Apr 25, 2024 Articles Polibrief: Consumer Data Privacy: State Efforts to Preserve Privacy Apr 16, 2024 Press Releases and Statements Self-Care Industry Representatives Participate in Capitol Hill Briefing Highlighting Legislative Priorities Apr 11, 2024